USPTO serial 78139935
GENPAK
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- CHOSID, ROBIN S
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with GENPAK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Cambridge, MA
Cambridge, MA
Johnson & Johnson Development Corporation
New Bunswick, NJ
Other trademarks owned by Johnson & Johnson Development Corporation
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael J. Bevilacqua, Esquire
MICHAEL J BEVILACQUA ESQ HALE AND DORR LLP60 STATE STBOSTON, MA 02109UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Bio-engineered cellular material which is a component of pharmaceutical and therapeutic preparations for use in the treatment of cancer, AIDS, metabolic diseases, neurodegenerative diseases, cardiovascular diseases, hematologic diseases, immune diseases and hormone deficiencies, namely, a packaging cell line that produces retroviral gene therapy vectors; pharmaceutical preparations for use in the treatment of cancer, AIDS, metabolic diseases, neurodegenerative diseases, cardiovascular diseases, and hormone deficiencies, and for packaging cell lines for use in the treatment of cancer, AIDS, metabolic diseases, neurodegenerative diseases, cardiovascular diseases and hormone deficiencies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Genetix Pharmaceuticals, Inc.
- Other trademarks owned by Genetix Pharmaceuticals, Inc.
- Other trademarks owned by Johnson & Johnson Development Corporation
- Other trademarks in Class 005
- Similar marks named GENPAK
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 1, 2006 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jun 27, 2006 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 27, 2006 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 26, 2005 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Aug 19, 2005 | EXT4 | SOU EXTENSION 4 FILED | — |
| Aug 19, 2005 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 12, 2005 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 27, 2005 | FAXX | FAX RECEIVED | — |
| Apr 5, 2005 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Apr 5, 2005 | EXT3 | SOU EXTENSION 3 FILED | — |
| Apr 5, 2005 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 7, 2004 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 30, 2004 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 30, 2004 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 28, 2004 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 26, 2004 | CFIT | CASE FILE IN TICRS | — |
| Apr 21, 2004 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 21, 2004 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 21, 2003 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 29, 2003 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 9, 2003 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 5, 2003 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 2, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 2, 2003 | PAPER RECEIVED | — | |
| Nov 4, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 3, 2002 | DOCK | ASSIGNED TO EXAMINER | — |